Bethesda, MD13 Active Studies

Follicular Lymphoma Clinical Trials in Bethesda, MD

Find 13 actively recruiting follicular lymphoma clinical trials in Bethesda, MD. Connect with local research sites and explore new treatment options.

13
Active Trials
3
Sponsors
28,595
Enrolling

Recruiting Follicular Lymphoma Studies in Bethesda

About Follicular Lymphoma Clinical Trials in Bethesda

Follicular lymphoma is the second most common type of non-Hodgkin lymphoma and is typically a slow-growing (indolent) cancer. It develops from B-cells in the lymph nodes. Treatment ranges from watchful waiting to immunotherapy, chemotherapy, and targeted agents.

There are currently 13 follicular lymphoma clinical trials recruiting participants in Bethesda, MD. These studies are seeking a combined 28,595 participants. Research is being sponsored by National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Cancer Institute (NCI). Clinical trial participation is free and participants receive study-related medical care at no cost.

Follicular Lymphoma Clinical Trials in Bethesda — FAQ

Are there follicular lymphoma clinical trials in Bethesda?

Yes, there are 13 follicular lymphoma clinical trials currently recruiting in Bethesda, MD. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Bethesda?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Bethesda research site will contact you about next steps.

Are clinical trials in Bethesda free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Bethesda studies also compensate for your time and travel.

What follicular lymphoma treatments are being tested?

The 13 active trials in Bethesda are testing new therapies including novel drugs, biologics, and treatment approaches for follicular lymphoma.

Data updated July 13, 2026 from ClinicalTrials.gov